医学界消化频道|研究发现!这些人的临床结局也受低病毒血症影响( 三 )


[6]Huang G, Lau W Y, Zhou W, et al. Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis B virus DNA levels and high preoperative hepatitis B surface antigen levels[J]. JAMA surgery, 2014, 149(6): 519-527.
[7]Wu J C, Huang Y H, Chau G Y, et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma[J]. Journal of hepatology, 2009, 51(5): 890-897.
[8]Sohn W, Paik Y H, Kim J M, et al. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma[J]. Annals of surgical oncology, 2014, 21(7): 2429-2435.
[9]Li M, Chen G, Cai C, et al. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence[J]. Digestion, 2011, 84(2): 134-141.
[10]Qu L S, Liu J X, Zhu J, et al. Risk factors for prognosis of hepatocellular carcinoma after curative resection in patients with low hepatitis B viral load[J]. Annals of hepatology, 2017, 16(3): 412-420.
[11]Kim T S, Sinn D H, Kang W, et al. Hepatitis B virus DNA levels and overall survival in hepatitis B‐related hepatocellular carcinoma patients with low‐level viremia[J]. Journal of gastroenterology and hepatology, 2019, 34(11): 2028-2035.
文末调研


推荐阅读